September 12th 2024
The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
French researchers suggest link between infant phototherapy and childhood skin moles
January 9th 2007Paris - According to a French study reported in the December issue of Archives of Dermatology, infants who received phototherapy for jaundice appear to have an increased risk of developing skin moles in childhood.
Study advises that all young acne patients be screened for depression
December 5th 2006Auckland, New Zealand ? A University of Auckland study conducted by researchers who have studied the link between teens with acne and those who have suicidal thoughts suggests that all young people seeking treatment for acne should be screened for depression.
Are your winter-rosy cheeks a little too rosy?
December 1st 2006An inflammatory skin disease shared by the likes of Princess Di, Bill Clinton and W.C.Fields, rosacea can start innocently with a flush on your cheeks that seems to last just a little too long. You may notice it after working out, eating spicy foods or even sipping a glass of red wine.
FDA Goals: Agency hopes to streamline risk communication, device review
December 1st 2006National report - The Food and Drug Administration's plans for 2007 and beyond include greater attention to postmarket risks and more timely reviews of medical devices, including those used for plastic and reconstructive surgery, spokesmen say.
Physician responds to Chester Valley concerns
December 1st 2006EDITOR'S NOTE: Dr. Leon Kircik is replying to a clarification from Chester Valley Pharmaceuticals that ran in our November issue on an article in the October issue, "Vehicles often drive treatment of difficult ailments." Atopiclair is Chester Valley Pharmaceutical's product. While Dr. Kircik was not the author of the article (he was interviewed by Senior Staff Correspondent John Jesitus) he did see the article before it went to press for his approval, as is Dermatology Times' standard practice with clinical articles.
Long-suffering rosacea patient asks, 'Doctors, please listen to your patients'
December 1st 2006In his Guest Commentary "Managing rosacea; practitioners discuss trends" (September 2006), Dr. William Baum presents his findings after moderating advisory panels across the country consisting of specialists talking about the many facets of rosacea.
New study shows betamethasone's effectiveness in treating psoriasis
November 7th 2006Bochum, Germany-Results of a recent study conducted at Ruhr University here suggest that the corticosteroid betamethasone is more effective for treatment of intertriginous psoriasis than is pimecrolimus or calcipotriol.